Organization: Health Canada
Year: 2024
Month: September
Request Number: A-2023-000618
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the Novo Nordisk Canada facility (Site A) on Argentina Rd, Mississauga, Ontario, starting around 02/12/2023.
Disposition: Disclosed in part
Number of pages: 361